OMDA

+ Watchlist + Portfolio

Omada Health, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $24.47
52-Week Range: $10.28 – $26.92
Market Cap: $1.45B
P/E (TTM): 35.39
EPS (TTM): 0.67
Dividend Yield: —

Advanced Metrics

Price/Book: 6.00
PEG Ratio: —
Return on Equity: 1.84%
Return on Assets: -0.09%
Gross Margin: 68.19%
Operating Margin: 4.04%
Profit Margin: 1.39%
Current Ratio: 3.91
Debt/Equity: —
Total Debt: $0.00
Free Cash Flow: $11.92M
Revenue Growth: 43.10%
Earnings Growth: —
Enterprise Value: $1.28B

OMDA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$89.19M	$122.78M	$169.80M	$260.21M
Cost of Revenue	$46.39M	$52.81M	$66.92M	$89.27M
Gross Profit	$42.79M	$69.97M	$102.88M	$170.94M
Research & Development	$26.17M	$33.74M	$35.92M	$40.68M
Selling, General & Admin	$88.97M	$102.23M	$110.61M	$142.23M
Operating Expenses	$115.14M	$135.97M	$146.53M	$182.91M
Operating Income	-$72.35M	-$66.00M	-$43.65M	-$11.97M
EBITDA	-$63.99M	-$58.36M	-$37.83M	-$4.75M
Pretax Income	-$72.52M	-$67.51M	-$47.14M	-$12.78M
Income Tax	$0.00	$0.00	$0.00	$0.00
Net Income	-$72.52M	-$67.51M	-$47.14M	-$12.78M
Diluted EPS	-1.52	-1.41	-0.85	-0.35
Diluted Shares	47.72M	47.72M	55.74M	36.64M

OMDA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$168.12M	$115.64M	$76.39M	$222.04M
Receivables	$11.67M	$16.44M	$23.92M	$35.22M
Inventory	$3.54M	$3.61M	$3.30M	$4.49M
Current Assets	$188.56M	$142.88M	$113.06M	$272.93M
Total Assets	$221.80M	$175.08M	$150.89M	$305.41M
Current Liabilities	$34.51M	$43.79M	$53.95M	$75.73M
Long-Term Debt	$28.89M	$29.38M	$29.77M	—
Total Debt	$30.81M	$30.58M	$30.19M	$0.00
Total Liabilities	$66.19M	$76.16M	$535.29M	$75.73M
Retained Earnings	-$329.32M	-$396.83M	-$443.97M	-$456.74M
Shareholders' Equity	$155.60M	$98.92M	-$384.40M	$229.68M
Working Capital	$154.04M	$99.09M	$59.11M	$197.21M

OMDA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$68.98M	-$49.74M	-$34.18M	$18.25M
Capital Expenditure	-$2.72M	-$2.92M	-$3.86M	-$5.83M
Free Cash Flow	-$71.70M	-$52.66M	-$38.04M	$12.42M
Depreciation & Amortisation	$4.33M	$4.45M	$4.80M	$5.49M
Stock-Based Compensation	$6.65M	$8.74M	$9.42M	$12.96M
Investing Cash Flow	-$2.72M	-$2.92M	-$3.86M	-$5.83M
Financing Cash Flow	$16.32M	$179.00K	-$1.21M	$133.22M
Net Change in Cash	-$55.38M	-$52.48M	-$39.25M	$145.64M

OMDA Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$61.37M	$68.03M	$75.85M	$78.05M	—
Cost of Revenue	$21.07M	$22.96M	$22.18M	$29.36M	—
Gross Profit	$40.31M	$45.07M	$53.66M	$48.69M	—
Research & Development	$10.02M	$10.30M	$11.55M	$12.70M	—
Selling, General & Admin	$34.63M	$37.28M	$38.83M	$40.78M	—
Operating Expenses	$44.65M	$47.58M	$50.38M	$53.47M	—
Operating Income	-$4.34M	-$2.51M	$3.28M	-$4.78M	—
EBITDA	-$2.87M	-$1.47M	$6.62M	-$1.44M	—
Pretax Income	-$5.31M	-$3.18M	$5.16M	-$2.97M	—
Income Tax	$0.00	$0.00	$0.00	$0.00	—
Net Income	-$5.31M	-$3.18M	$5.16M	-$2.97M	—
Diluted EPS	-0.24	-0.06	0.08	-0.05	0.08
Diluted Shares	21.97M	57.66M	63.93M	58.92M	63.95M

OMDA Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$59.40M	$223.15M	$198.63M	$222.04M	$211.76M
Receivables	$29.28M	$33.29M	$41.45M	$35.22M	$39.98M
Inventory	$3.04M	$3.47M	$3.15M	$4.49M	$3.83M
Current Assets	$102.55M	$271.11M	$254.90M	$272.93M	$269.43M
Total Assets	$141.18M	$302.97M	$287.47M	$305.41M	$302.80M
Current Liabilities	$49.23M	$57.99M	$70.12M	$75.73M	$68.68M
Long-Term Debt	$29.87M	$29.97M	—	—	—
Total Debt	$30.08M	$29.97M	$0.00	$0.00	—
Total Liabilities	$82.20M	$88.76M	$70.12M	$75.73M	$68.68M
Retained Earnings	-$453.41M	-$458.73M	-$461.90M	-$456.74M	-$459.71M
Shareholders' Equity	$58.98M	$214.21M	$217.35M	$229.68M	$234.12M
Working Capital	$53.33M	$213.12M	$184.78M	$197.21M	$200.75M

OMDA Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$16.12M	$2.86M	$10.13M	$21.38M	-$11.83M
Capital Expenditure	-$1.25M	-$1.25M	-$1.99M	-$1.35M	-$1.56M
Free Cash Flow	-$17.37M	$1.61M	$8.15M	$20.03M	-$13.39M
Depreciation & Amortisation	$1.33M	$1.35M	$1.36M	$1.45M	$1.51M
Stock-Based Compensation	$2.84M	$2.83M	$3.54M	$3.75M	$4.21M
Investing Cash Flow	-$1.25M	-$1.25M	-$1.99M	-$1.35M	-$1.56M
Financing Cash Flow	$372.00K	$162.14M	-$32.66M	$3.38M	$3.12M
Net Change in Cash	-$17.00M	$163.75M	-$24.52M	$23.41M	-$10.27M

Market Snapshot

About

Omada Health is a virtual care platform specializing in chronic disease management and prevention. The company offers digital programs for prediabetes, diabetes, hypertension, and musculoskeletal conditions combining personalized coaching, curriculum, and connected devices. Omada partners with employers and health plans to deliver care remotely.